SMTL ID : 5jgd.1

Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 12

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

monomer

Ligands

1 x 6KD: N-(2-isopropoxy-3-(4-methylpiperazine-1-carbonyl)phenyl)-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxamide(Non-covalent)

6KD.1: 16 residues within 4Å: Chain A: V.17, R.19, V.25, A.36, K.38, M.79, E.80, Y.81, A.82, G.85, S.86, N.89, P.135, L.138, C.149, D.150 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.25, A:L.138 Hydrogen bonds: A:A.82, A:S.86, A:D.150, A:D.150

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Muraoka, T. et al., Discovery of a potent and highly selective transforming growth factor beta receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD). Bioorg.Med.Chem. (2016)

Release Date

2016-07-27

Peptides

TAK1 kinase - TAB1 chimera fusion protein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

TAK1 kinase - TAB1 chimera fusion protein

Related Entries With Identical Sequence